We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+30.88%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.73B
AUM Growth
+$507M
Cap. Flow
+$31.1M
Cap. Flow %
1.14%
Top 10 Hldgs %
21.62%
Holding
273
New
30
Increased
132
Reduced
65
Closed
25

Sector Composition

1 Technology 29.35%
2 Healthcare 21.4%
3 Industrials 18.56%
4 Financials 13.16%
5 Consumer Discretionary 8.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRDO icon
1
Credo Technology Group
CRDO
$37.8B
$84.4M 3.09%
911,514
-317,519
-26% -$18.5M
AVAV icon
2
AeroVironment
AVAV
$7.2B
$72M 2.64%
252,686
+27,868
+12% +$4.72M
KTOS icon
3
Kratos Defense & Security Solutions
KTOS
$8.63B
$70.2M 2.57%
1,510,418
+32,547
+2% +$1.18M
TMDX icon
4
Transmedics
TMDX
$2.56B
$58.9M 2.16%
439,329
-15,465
-3% -$1.7M
TTMI icon
5
TTM Technologies
TTMI
$13.7B
$57.3M 2.1%
1,403,317
-36,614
-3% -$1.01M
SLNO
6
DELISTED
Soleno Therapeutics
SLNO
$56.4M 2.07%
672,908
+108,427
+19% +$8.12M
PLMR icon
7
Palomar
PLMR
$3.59B
$49.5M 1.82%
321,147
-55,549
-15% -$8.6M
QTWO icon
8
Q2 Holdings
QTWO
$3.43B
$47.9M 1.76%
512,016
+18,583
+4% +$1.57M
VRNS icon
9
Varonis Systems
VRNS
$5.46B
$47.8M 1.75%
942,703
+35,638
+4% +$1.62M
RMBS icon
10
Rambus
RMBS
$11B
$45.5M 1.67%
710,123
+179,421
+34% +$9.61M
BBIO icon
11
BridgeBio Pharma
BBIO
$15.9B
$44.1M 1.62%
1,021,257
-124,234
-11% -$4.52M
LITE icon
12
Lumentum
LITE
$57B
$42.4M 1.55%
446,102
+22,012
+5% +$1.56M
AX icon
13
Axos Financial
AX
$5.66B
$42.1M 1.54%
553,591
+20,005
+4% +$1.35M
SKWD icon
14
Skyward Specialty Insurance
SKWD
$2.4B
$41.5M 1.52%
717,760
-97,124
-12% -$5.6M
OLLI icon
15
Ollie's Bargain Outlet
OLLI
$4.02B
$40.6M 1.49%
307,841
+28,026
+10% +$3.21M
FN icon
16
Fabrinet
FN
$17.1B
$40.1M 1.47%
136,218
-3,273
-2% -$729K
IDCC icon
17
InterDigital
IDCC
$6.73B
$39.1M 1.43%
174,499
+23,402
+15% +$4.96M
VITL icon
18
Vital Farms
VITL
$581M
$39.1M 1.43%
1,015,225
+37,028
+4% +$1.25M
AGYS icon
19
Agilysys
AGYS
$3B
$38.6M 1.42%
337,102
+103,614
+44% +$9.35M
RDNT icon
20
RadNet
RDNT
$4.89B
$38.3M 1.4%
672,356
+27,134
+4% +$1.49M
EYE icon
21
National Vision
EYE
$1.66B
$37.3M 1.37%
1,621,925
+278,597
+21% +$4.75M
GH icon
22
Guardant Health
GH
$20.7B
$36.4M 1.34%
699,922
+168,498
+32% +$7.53M
TBBK icon
23
The Bancorp
TBBK
$2.85B
$35.7M 1.31%
626,413
+78,144
+14% +$3.95M
FRPT icon
24
Freshpet
FRPT
$2.78B
$35.4M 1.3%
521,175
+11,727
+2% +$916K
BWIN
25
Baldwin Insurance Group
BWIN
$2.66B
$34.5M 1.27%
806,290
+61,669
+8% +$2.5M

Similar funds

Emerald Advisers's Q2 2025 Portfolio in Review

As of Q2 2025, Emerald Advisers held 273 positions worth $2.73B, up 23% from $2.22B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Emerald Advisers's Q2 2025 filing shows 30 new, 132 increased, 65 reduced and 25 closed positions. Its largest new stake was Mercury Systems: 456,713 shares worth $24.6M. The largest sale was FTAI Aviation, an estimated $52.2M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.

  • Emerald Advisers's largest Q2 2025 buy was Mercury Systems: 456,713 shares worth $24.6M.
  • Emerald Advisers added most to Clearwater Analytics in Q2 2025, an estimated $13.2M increase.
  • Emerald Advisers's biggest Q2 2025 reduction was FTAI Aviation, cutting an estimated $52.2M.
  • Emerald Advisers fully exited Blueprint Medicines in Q2 2025, selling an estimated $35.5M.
  • Emerald Advisers's ten largest holdings make up 22% of its $2.73B portfolio in Q2 2025.
  • Emerald Advisers opened 30 new positions and closed 25 in Q2 2025.
  • Emerald Advisers's portfolio value rose 23% quarter-over-quarter to $2.73B.

Based on Emerald Advisers's 13F filing for Q2 2025, filed 4 Aug 2025.